Literature DB >> 34619714

Integration of Patient-reported Outcomes Assessment Into Routine Care for Patients Receiving Residential Treatment for Alcohol and/or Substance Use Disorder.

Cameron M Yi1, Andrew S Huhn, J Gregory Hobelmann, John Finnerty, Bernadette Solounias, Kelly E Dunn.   

Abstract

BACKGROUND: More than 3 million individuals receive treatment for alcohol use disorder (AUD) and/or substance use disorder each year, yet there exists no standardized method for measuring patient success in treatment. Quantifying a more comprehensive assessment of treatment outcomes could identify the relative efficacy of different treatment strategies for individuals with AUD/substance use disorders, and help patients to identify, in advance, appropriate treatment options.
METHODS: This study developed and embedded patient-reported outcome measures into the routine clinical operations of a residential treatment program. Surveys assessed demographics, drug use history, physical and mental health, and quality of life. Outcomes were assessed among participants at admission (n = 961) and in patients who completed the survey at time of discharge (n = 633).
RESULTS: Past 30-day alcohol and/or opioid use at admission were correlated with worse self-reported physical and mental health, sleep, and quality of life, and greater negative affect and craving ( P s < 0.05). Previous history of treatment and/or withdrawal management were associated with worse self-reported physical and mental health, quality of life, and increased craving ( P s < 0.05). Physical and mental health improved across timepoints and was most pronounced when comparing persons receiving treatment for opioid use disorder versus AUD, wherein persons with opioid use disorder had worse physical health at all time points, and greater sleep disturbance and negative affect at discharge ( P s < 0.05).
CONCLUSIONS: It is feasible to embed patient outcome monitoring into routine clinic operations, which could be used in the future to tailor treatment plans.
Copyright © 2021 American Society of Addiction Medicine.

Entities:  

Mesh:

Year:  2021        PMID: 34619714      PMCID: PMC8980111          DOI: 10.1097/ADM.0000000000000927

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   4.647


  28 in total

1.  Addiction severity assessment tool: development of a self-report measure for clients in substance abuse treatment.

Authors:  Stephen F Butler; Simon H Budman; Michael D McGee; Michael Sean Davis; Rebecca Cornelli; Leslie C Morey
Journal:  Drug Alcohol Depend       Date:  2005-07-01       Impact factor: 4.492

2.  Likert scales, levels of measurement and the "laws" of statistics.

Authors:  Geoff Norman
Journal:  Adv Health Sci Educ Theory Pract       Date:  2010-02-10       Impact factor: 3.853

3.  Analyzing and interpreting data from likert-type scales.

Authors:  Gail M Sullivan; Anthony R Artino
Journal:  J Grad Med Educ       Date:  2013-12

4.  Development and initial evaluation of the Brief Addiction Monitor (BAM).

Authors:  John S Cacciola; Arthur I Alterman; Dominick Dephilippis; Michelle L Drapkin; Charles Valadez; Natalie C Fala; David Oslin; James R McKay
Journal:  J Subst Abuse Treat       Date:  2012-08-14

Review 5.  The clinical significance of drug craving.

Authors:  Stephen T Tiffany; Jennifer M Wray
Journal:  Ann N Y Acad Sci       Date:  2011-12-16       Impact factor: 5.691

6.  Myocardial infarction survivors: age and gender differences in physical health, psychosocial state and regimen adherence.

Authors:  V S Conn; S G Taylor; P B Abele
Journal:  J Adv Nurs       Date:  1991-09       Impact factor: 3.187

7.  Applying quality-of-life data formally and systematically into clinical practice.

Authors:  Marlene H Frost; Amy E Bonomi; Joseph C Cappelleri; Holger J Schünemann; Timothy J Moynihan; Neil K Aaronson
Journal:  Mayo Clin Proc       Date:  2007-10       Impact factor: 7.616

8.  Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey.

Authors:  Joel Swendsen; Kevin P Conway; Louisa Degenhardt; Lisa Dierker; Meyer Glantz; Robert Jin; Kathleen R Merikangas; Nancy Sampson; Ronald C Kessler
Journal:  Addiction       Date:  2009-06-22       Impact factor: 6.526

9.  Quality of life improved following in-patient substance use disorder treatment.

Authors:  Adrian R Pasareanu; Anne Opsal; John-Kåre Vederhus; Øistein Kristensen; Thomas Clausen
Journal:  Health Qual Life Outcomes       Date:  2015-03-14       Impact factor: 3.186

10.  Performance measures for substance use disorders--what research is needed?

Authors:  Deborah W Garnick; Constance M Horgan; Andrea Acevedo; Frank McCorry; Constance Weisner
Journal:  Addict Sci Clin Pract       Date:  2012-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.